224 related articles for article (PubMed ID: 30431243)
1. [Cardiac complications of sickle cell disease in children].
Astadicko I; Dresse MF; Seghaye MC
Rev Med Liege; 2018 Nov; 73(11):550-556. PubMed ID: 30431243
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.
Niss O; Quinn CT; Lane A; Daily J; Khoury PR; Bakeer N; Kimball TR; Towbin JA; Malik P; Taylor MD
JACC Cardiovasc Imaging; 2016 Mar; 9(3):243-52. PubMed ID: 26897687
[TBL] [Abstract][Full Text] [Related]
3. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
Kaushik N; Eckrich MJ; Parra D; Yang E
Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular complications and risk of death in sickle-cell disease.
Gladwin MT
Lancet; 2016 Jun; 387(10037):2565-74. PubMed ID: 27353687
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary complications of sickle cell disease in children].
Pincez T; Calamy L; Germont Z; Lemoine A; Lopes AA; Massiot A; Tencer J; Thivent C; Hadchouel A
Arch Pediatr; 2016 Oct; 23(10):1094-1106. PubMed ID: 27642150
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
Tantawy AA; Adly AA; Ismail EA
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
[TBL] [Abstract][Full Text] [Related]
7. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
8. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
9. Chronic Pulmonary Complications of Sickle Cell Disease.
Mehari A; Klings ES
Chest; 2016 May; 149(5):1313-24. PubMed ID: 26836905
[TBL] [Abstract][Full Text] [Related]
10. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary complications of sickle cell disease in children.
Caboot JB; Allen JL
Curr Opin Pediatr; 2008 Jun; 20(3):279-87. PubMed ID: 18475096
[TBL] [Abstract][Full Text] [Related]
12. [Cardiopulmonary complications in sickle cell anemia].
Rojas-Jiménez S; Lopera-Valle J; Yabur-Espítia M
Arch Cardiol Mex; 2013; 83(4):289-94. PubMed ID: 24215682
[TBL] [Abstract][Full Text] [Related]
13. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
Cho G; Hambleton IR
Cochrane Database Syst Rev; 2011 Sep; (9):CD008360. PubMed ID: 21901721
[TBL] [Abstract][Full Text] [Related]
14. Vascular complications of sickle cell disease.
Usmani A; Machado RF
Clin Hemorheol Microcirc; 2018; 68(2-3):205-221. PubMed ID: 29614633
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia.
Gerry JL; Bulkley BH; Hutchins GM
Am J Cardiol; 1978 Aug; 42(2):211-6. PubMed ID: 150786
[TBL] [Abstract][Full Text] [Related]
16. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance.
Chaudry RA; Cikes M; Karu T; Hutchinson C; Ball S; Sutherland G; Rosenthal M; Bush A; Crowley S
Arch Dis Child; 2011 Feb; 96(2):131-6. PubMed ID: 21030373
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary complications of hemoglobinopathies.
Vij R; Machado RF
Chest; 2010 Oct; 138(4):973-83. PubMed ID: 20923801
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.
Mandese V; Bigi E; Bruzzi P; Palazzi G; Predieri B; Lucaccioni L; Cellini M; Iughetti L
BMC Pediatr; 2019 Feb; 19(1):56. PubMed ID: 30744584
[TBL] [Abstract][Full Text] [Related]
19. Early recognition of pulmonary complications of sickle cell disease.
Almusally RM
Saudi Med J; 2023 Jan; 44(1):10-18. PubMed ID: 36634940
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
